Search Result "Dopaminergic hypothesis of schizophrenia"

Genetic Data Supporting the NMDA Glutamate Receptor Hypothesis for Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 12 Year: 2012 Page: 1580-1592
Author(s): Thomas L. Schwartz, Shilpa Sachdeva, Stephen M. Stahl

Glutamate Hypothesis of Schizophrenia and Approach for Possible Therapeutic Drugs

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 4 Issue: 2 Year: 2004 Page: 147-154
Author(s): Kenji Hashimoto, Naoe Okamura, Eiji Shimizu, Masaomi Iyo

Glutamate and Schizophrenia

Journal: Current Neuropharmacology
Volume: 1 Issue: 4 Year: 2003 Page: 351-370
Author(s): B. N.M. van Berckel

The Role of Microbial Agents in the Etiology of Schizophrenia: An Infectious Hypothesis for Psychosis?

Journal: Current Immunology Reviews
Volume: 7 Issue: 1 Year: 2011 Page: 57-63
Author(s): Blanca Gutierrez, Gabriel Heiber, Francisco Torres-Gonzalez, Jorge A. Cervilla

Oestrogen-A Protective Factor in Schizophrenia?

Journal: Current Psychiatry Reviews
Volume: 2 Issue: 3 Year: 2006 Page: 339-352
Author(s): Heinz Hafner, Hannelore Ehrenreich, Wagner F. Gattaz, Mario R. Louza, Anita Riecher-Rossler, Jayashri Kulkarni

Understanding Gender Differences in Schizophrenia: A Review of the Literature

Journal: Current Psychiatry Reviews
Volume: 2 Issue: 2 Year: 2006 Page: 255-265
Author(s): Rachel Taylor, Robyn Langdon

Schizophrenia and Liver Dysfunction Caused by Portacaval Shunting

Journal: Current Psychiatry Reviews
Volume: 3 Issue: 3 Year: 2007 Page: 205-212
Author(s): Jens Kroll

Review Article

Discovery and Development of Non-Dopaminergic Agents for the Treatment of Schizophrenia: Overview of the Preclinical and Early Clinical Studies

Journal: Current Medicinal Chemistry
Volume: 26 Issue: 25 Year: 2019 Page: 4885-4913
Author(s): Agnieszka Jankowska,Grzegorz Satała,Anna Partyka,Anna Wesołowska,Andrzej J. Bojarski,Maciej Pawłowski,Grażyna Chłoń-Rzepa

Kynurenine Pathway in Schizophrenia: Pathophysiological and Therapeutic Aspects

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 130-136
Author(s): Norbert Muller, Aye-Mu Myint, Markus J. Schwarz

Review Article

Cholecystokinin-Mediated Neuromodulation of Anxiety and Schizophrenia: A “Dimmer-Switch” Hypothesis

Journal: Current Neuropharmacology
Volume: 19 Issue: 7 Year: 2021 Page: 925-938
Author(s): Santiago J. Ballaz,Michel Bourin

Previous   Next

Go To   Results 1 - 1 of 736

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


© 2024 Bentham Science Publishers | Privacy Policy